Cite

HARVARD Citation

    McCaleb, M. et al. (n.d.). Pharmacodynamic efficacy of IONIS-FB-LRX, a complement factor B antisense oligonucleotide, in a phase 1 clinical study. Molecular immunology. pp. 187-188. [Online]. 
  
Back to record